Related references
Note: Only part of the references are listed.Toward the Development of a Potent and Selective Organoruthenium Mammalian Sterile 20 Kinase Inhibitor
Ruchi Anand et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Pyrrolocarbazoles as checkpoint 1 kinase inhibitors
Helene Henon et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles
Elisabeth Conchon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Extremely Tight Binding of a Ruthenium Complex to Glycogen Synthase Kinase 3
G. Ekin Atilla-Gokcumen et al.
CHEMBIOCHEM (2008)
Synthesis, in vitro antiproliferative activities, and Chk1 inhibitory properties of pyrrolo[3,4-a]carbazole-1,3-diones, pyrrolo[3,4-c]carbazole-1,3-diones, and 2-aminopyridazino[3,4-a]pyrrolo[3,4-c]carbazole-1,3,4,7-tetraone
Elisabeth Conchon et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide
Elisabeth Conchon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and reactivity of 7-azaindole (1H-pyrrolo[2,3-b]pyridine)
Florence Popowycz et al.
TETRAHEDRON (2007)
Bis-imide granulatimide analogues as potent Checkpoint 1 kinase inhibitors
Helene Henon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Synthesis and biological activities of isogranulatimide analogues
Bernadette Hugon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Ruthenium half-sandwich complexes as protein kinase inhibitors:: An N-succinimidyl ester for rapid derivatizations of the cyclopentadienyl moiety
Howard Bregman et al.
ORGANIC LETTERS (2006)
Synthesis and biological activities of 7-aza rebeccamycin analogues bearing the sugar moiety on the nitrogen of the pyridine ring
Samir Messaoudi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Organometallic compounds with biological activity: A very selective and highly potent cellular inhibitor for glycogen synthase kinase 3
G. Ekin Atilla-Gokcumen et al.
CHEMBIOCHEM (2006)
Synthesis of N-alkyl substituted bioactive indolocarbazoles related to Go6976
Sudipta Roy et al.
TETRAHEDRON (2006)
Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
GJ Wells et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthesis and structure-activity relationships of novel poly(ADP-ribose) polymerase-1 inhibitors
M Tao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents
S Routier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: Discovery of potent and selective protein kinase inhibitors
H Bregman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Synthesis of bisindolylmaleimides related to GF109203x and their efficient conversion to the bioactive indolocarbazoles
Sudipta Roy et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2006)
Synthesis and cytotoxicities of 7-aza rebeccamycin analogues bearing various substituents on the sugar moiety, on the imide nitrogen and on the carbazole framework
S Messaoudi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis of bridged aza-rebeccamycin analogues
S Messaoudi et al.
TETRAHEDRON (2005)
New cytotoxic bisindole alkaloids with protein tyrosine kinase inhibitory activity from a myxomycete Lycogala epidendrum
T Hosoya et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11
MG Saulnier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Syntheses and biological activities of rebeccamycin analogues with uncommon sugars
GS Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents
S Routier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Synthesis of 7-Keto-Go6976 (ICP-103)
S Roy et al.
SYNTHETIC COMMUNICATIONS (2005)
Switching on a signaling pathway with an organoruthenium complex
DS Williams et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Synthetic approaches to indolo[6,7-a]pyrrolo[3,4-c]carbazoles:: Potent cyclin D1/CDK4 inhibitors
MM Faul et al.
JOURNAL OF ORGANIC CHEMISTRY (2004)
Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents.: Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-β-D-glucopyranosyl]-5H,13H-benzo[b]-thienyl[2,3-α]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model
BN Balasubramanian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Synthesis of indolo[2,3-a]carbazole glycoside analogs of rebeccamycin:: inhibitors of cyclin D1-CDK4
MM Faul et al.
TETRAHEDRON LETTERS (2004)
Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors
GX Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
1,7-Annulated indolocarbazoles as cyclin-dependent kinase inhibitors
RS Al-Awar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Synthesis of a staurosporine analogue possessing a 7-azaindole unit instead of an indole moiety
S Messaoudi et al.
TETRAHEDRON LETTERS (2004)
An organometallic inhibitor for glycogen synthase kinase 3
H Bregman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives
P Moreau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors
C Sanchez-Martinez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety
F Anizon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Novel, potent and selective cyclin D1/CDK4 inhibitors:: Indolo[6,7-a]pyrrolo[3,4-c]carbazoles
TA Engler et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Synthesis of isogranulatimides A and B analogues possessing a 7-azaindole unit instead of an indole moiety
B Hugon et al.
TETRAHEDRON LETTERS (2003)
Synthesis of quinolinyl/isoquinolinyl[a]pyrrolo [3,4-c] carbazoles as cyclin D1/CDK4 inhibitors
GX Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety
C Marminon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Synthesis of granulatimide positional analogues
T Yoshida et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Structural basis for Chk1 inhibition by UCN-01
B Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synthesis and biological evaluation of 7-azaindolocarbazoles
S Routier et al.
TETRAHEDRON (2002)
New synthetic route to granulatimide and its structural analogues
T Yoshida et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2002)
Tyrosine kinase inhibitors: From rational design to clinical trials
P Traxler et al.
MEDICINAL RESEARCH REVIEWS (2001)
Chemical inhibitors of protein kinases
AJ Bridges
CHEMICAL REVIEWS (2001)
Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine
D Curman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Granulatimide and 6-bromogranulatimide, minor alkaloids of the Brazilian ascidian Didemnum granulatum
R Britton et al.
JOURNAL OF NATURAL PRODUCTS (2001)
Development of inhibitors for protein tyrosine kinases
FA Al-Obeidi et al.
ONCOGENE (2000)
Protein kinases as therapeutic targets
R Sridhar et al.
PHARMACEUTICAL RESEARCH (2000)
Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products
S Zhao et al.
NATURE (2000)
Improved synthesis of isogranulatimide, a G2 checkpoint inhibitor. Syntheses of didemnimide C, isodidemnimide A, neodidemnimide A, 17-methylgranulatimide, and isogranulatimides A-C
E Piers et al.
JOURNAL OF ORGANIC CHEMISTRY (2000)
Cyclin-dependent kinase inhibitors: Useful targets in cell cycle regulation
TM Sielecki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
